title: Surgical treatment of recurrent cervical cancer: state of the art and new achievements.
abstract: This article review the current situation of the exenterative procedures as part of the treatment of recurrent cervical cancer after radiation. Pelvic exenteration has been proven the only curative choice of treatment in selected cases of this clinical situation. A review of historical and recent published series have shown an increase of 5-y survival from 30 to 42 %. Almost one out of two patients will suffer complications of some kind, and one out of three will have a severe complication with pelvic exenteration. During the past sixty years, a number of outstanding improvements have been achieved - not only in surgical outcomes, but also in quality of life - owing to new reconstructive approaches. Women facing an exenterative procedure must be counseled carefully about the risks and long-term concerns related to the procedure. Each should undergo a comprehensive evaluation to make sure there is no evidence of unresectable or metastatic disease that would make her an unsuitable candidate for exenteration.
authors.affiliation: Department of Gynecologic Oncology, M. D. Anderson International España, Madrid, Spain. lchiva@mdanderson.es
authors.forename: Luis M
authors.initials: LM
authors.lastname: Chiva
authors.forename: Fernando
authors.initials: F
authors.lastname: Lapuente
authors.forename: Lucía
authors.initials: L
authors.lastname: González-Cortijo
authors.forename: Antonio
authors.initials: A
authors.lastname: González-Martín
authors.forename: Alejandro
authors.initials: A
authors.lastname: Rojo
authors.forename: Juan F
authors.initials: JF
authors.lastname: García
authors.forename: Natalia
authors.initials: N
authors.lastname: Carballo
mesh_terms: D005260:Female; D013509:Gynecologic Surgical Procedures / Q000379:methods; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D002583:Uterine Cervical Neoplasms / Q000601:surgery*